awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36488198-737F8513-2AE7-41F9-A511-932858129FD4
Q36488198-737F8513-2AE7-41F9-A511-932858129FD4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36488198-737F8513-2AE7-41F9-A511-932858129FD4
Optimal therapy for platinum-resistant recurrent ovarian cancer: doxorubicin, gemcitabine or topotecan?
P2860
Q36488198-737F8513-2AE7-41F9-A511-932858129FD4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36488198-737F8513-2AE7-41F9-A511-932858129FD4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5947692198404ba45a6ccfb53323c78884abca16
P2860
Second-line carboplatin and gemcitabine in platinum sensitive ovarian cancer--a dose-finding study by the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Ovarian Cancer Study Group.